Genetics irrelevant for treatment success in Noonan syndrome

07 Apr 2022


Noonan syndrome patients treated with growth hormone before puberty show the same beneficial outcomes, regardless of their PTPN11 mutation status, according to research published in Endocrine Connections.

medwireNews


Related Topics

Neuroendocrinology

Share this story